Thomas A Caneris Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Thomas A Caneris.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Thomas A Caneris. Thomas A Caneris is Sr. VP, HR and General Counsel in LSI INDUSTRIES INC ($LYTS) and SVP, GC and Secretary in PharMerica CORP ($PMC).
Latest Insider Trading Transactions of Thomas A Caneris
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Aug 20 2020 | LYTS | LSI INDUSTRIES INC | Caneris Thomas A | Sr. VP, HR and Gene ... | Option Exercise | A | 6.80 | 21,928 | 149,110 | 21,928 | |
Aug 20 2020 | LYTS | LSI INDUSTRIES INC | Caneris Thomas A | Sr. VP, HR and Gene ... | Grant | A | 0.00 | 10,654 | 0 | 10,654 | 0 to 10.7 K |
Aug 23 2019 | LYTS | LSI INDUSTRIES INC | Caneris Thomas A | Sr. VP, HR and Gene ... | Option Exercise | A | 3.83 | 73,404 | 281,137 | 73,404 | |
Aug 23 2019 | LYTS | LSI INDUSTRIES INC | Caneris Thomas A | Sr. VP, HR and Gene ... | Option Exercise | A | 3.83 | 73,404 | 281,137 | 73,404 | |
Aug 05 2019 | LYTS | LSI INDUSTRIES INC | Caneris Thomas A | Sr. VP, HR and Gene ... | Option Exercise | A | 4.04 | 100,000 | 404,000 | 100,000 | |
Dec 08 2017 | PMC | PharMerica CORP | Caneris Thomas A | SVP, GC and Secreta ... | Option Exercise | D | 10.84 | 9,588 | 103,934 | 0 | |
Dec 08 2017 | PMC | PharMerica CORP | Caneris Thomas A | SVP, GC and Secreta ... | Option Exercise | D | 0.00 | 29,672 | 0 | 0 | |
Dec 08 2017 | PMC | PharMerica CORP | Caneris Thomas A | SVP, GC and Secreta ... | Option Exercise | A | 0.00 | 29,672 | 0 | 29,672 | |
Dec 08 2017 | PMC | PharMerica CORP | Caneris Thomas A | SVP, GC and Secreta ... | Sell | D | 29.25 | 87,023 | 2,545,423 | 0 | 87 K to 0 (-100.00 %) |
Dec 08 2017 | PMC | PharMerica CORP | Caneris Thomas A | SVP, GC and Secreta ... | Gift | G | 0.00 | 2,753 | 0 | 87,023 | 89.8 K to 87 K (-3.07 %) |
Apr 11 2017 | PMC | PharMerica CORP | Caneris Thomas A | SVP, GC and Secreta ... | Grant | A | 0.00 | 9,998 | 0 | 89,776 | 79.8 K to 89.8 K (+12.53 %) |
Mar 28 2017 | PMC | PharMerica CORP | Caneris Thomas A | SVP, GC and Secreta ... | Payment of Exercise | F | 23.60 | 1,541 | 36,368 | 79,778 | 81.3 K to 79.8 K (-1.90 %) |
Mar 28 2017 | PMC | PharMerica CORP | Caneris Thomas A | SVP, GC and Secreta ... | Grant | A | 0.00 | 4,253 | 0 | 81,319 | 77.1 K to 81.3 K (+5.52 %) |
Mar 21 2017 | PMC | PharMerica CORP | Caneris Thomas A | SVP, GC and Secreta ... | Payment of Exercise | F | 23.15 | 982 | 22,733 | 77,066 | 78 K to 77.1 K (-1.26 %) |
Mar 21 2017 | PMC | PharMerica CORP | Caneris Thomas A | SVP, GC and Secreta ... | Payment of Exercise | F | 22.50 | 1,374 | 30,915 | 78,048 | 79.4 K to 78 K (-1.73 %) |
Mar 15 2017 | PMC | PharMerica CORP | Caneris Thomas A | SVP, GC and Secreta ... | Payment of Exercise | F | 23.00 | 1,239 | 28,497 | 79,422 | 80.7 K to 79.4 K (-1.54 %) |
Mar 23 2016 | PMC | PharMerica CORP | Caneris Thomas A | SVP, GC and Secreta ... | Payment of Exercise | F | 20.45 | 1,386 | 28,344 | 80,661 | 82 K to 80.7 K (-1.69 %) |
Mar 21 2016 | PMC | PharMerica CORP | Caneris Thomas A | SVP, GC and Secreta ... | Grant | A | 0.00 | 11,548 | 0 | 82,047 | 70.5 K to 82 K (+16.38 %) |
Mar 21 2016 | PMC | PharMerica CORP | Caneris Thomas A | SVP, GC and Secreta ... | Payment of Exercise | F | 19.99 | 7,631 | 152,544 | 70,499 | 78.1 K to 70.5 K (-9.77 %) |
Mar 21 2016 | PMC | PharMerica CORP | Caneris Thomas A | SVP, GC and Secreta ... | Grant | A | 0.00 | 14,918 | 0 | 78,130 | 63.2 K to 78.1 K (+23.60 %) |
Mar 15 2016 | PMC | PharMerica CORP | Caneris Thomas A | SVP, GC and Secreta ... | Payment of Exercise | F | 21.65 | 1,520 | 32,908 | 63,212 | 64.7 K to 63.2 K (-2.35 %) |
Mar 09 2016 | PMC | PharMerica CORP | Caneris Thomas A | SVP, GC and Secreta ... | Payment of Exercise | F | 23.48 | 2,667 | 62,621 | 64,732 | 67.4 K to 64.7 K (-3.96 %) |
May 14 2015 | PMC | PharMerica CORP | Caneris Thomas A | SVP, GC and Secreta ... | Sell | S | 30.01 | 7,052 | 211,650 | 67,589 | 74.6 K to 67.6 K (-9.45 %) |
Mar 23 2015 | PMC | PharMerica CORP | Caneris Thomas A | SVP, GC and Secreta ... | Payment of Exercise | F | 27.85 | 7,148 | 199,072 | 74,641 | 81.8 K to 74.6 K (-8.74 %) |
Mar 23 2015 | PMC | PharMerica CORP | Caneris Thomas A | SVP, GC and Secreta ... | Grant | A | 0.00 | 8,126 | 0 | 81,789 | 73.7 K to 81.8 K (+11.03 %) |
Mar 23 2015 | PMC | PharMerica CORP | Caneris Thomas A | SVP, GC and Secreta ... | Grant | A | 0.00 | 14,200 | 0 | 73,663 | 59.5 K to 73.7 K (+23.88 %) |
Mar 13 2015 | PMC | PharMerica CORP | Caneris Thomas A | SVP, GC and Secreta ... | Sell | S | 26.52 | 7,495 | 198,801 | 59,463 | 67 K to 59.5 K (-11.19 %) |
Mar 13 2015 | PMC | PharMerica CORP | Caneris Thomas A | SVP, GC and Secreta ... | Payment of Exercise | F | 26.22 | 1,092 | 28,632 | 66,958 | 68.1 K to 67 K (-1.60 %) |
Mar 06 2015 | PMC | PharMerica CORP | Caneris Thomas A | SVP, GC and Secreta ... | Option Exercise | M | 18.48 | 33,565 | 620,281 | 0 | |
Mar 06 2015 | PMC | PharMerica CORP | Caneris Thomas A | SVP, GC and Secreta ... | Option Exercise | M | 14.89 | 25,000 | 372,250 | 0 | |
Mar 06 2015 | PMC | PharMerica CORP | Caneris Thomas A | SVP, GC and Secreta ... | Sell | S | 27.02 | 17,253 | 466,257 | 68,050 | 85.3 K to 68.1 K (-20.23 %) |
Mar 06 2015 | PMC | PharMerica CORP | Caneris Thomas A | SVP, GC and Secreta ... | Payment of Exercise | F | 27.39 | 46,229 | 1,266,212 | 85,303 | 131.5 K to 85.3 K (-35.15 %) |
Mar 06 2015 | PMC | PharMerica CORP | Caneris Thomas A | SVP, GC and Secreta ... | Buy | M | 18.48 | 33,565 | 620,281 | 131,532 | 98 K to 131.5 K (+34.26 %) |
Mar 06 2015 | PMC | PharMerica CORP | Caneris Thomas A | SVP, GC and Secreta ... | Buy | M | 14.89 | 25,000 | 372,250 | 97,967 | 73 K to 98 K (+34.26 %) |
Jan 22 2015 | PMC | PharMerica CORP | Caneris Thomas A | SVP, GC and Secreta ... | Payment of Exercise | F | 23.64 | 2,553 | 60,353 | 73,149 | 75.7 K to 73.1 K (-3.37 %) |
May 13 2014 | PMC | PharMerica CORP | Caneris Thomas A | SVP, GC and Secreta ... | Option Exercise | M | 10.84 | 28,764 | 311,802 | 9,588 | |
May 13 2014 | PMC | PharMerica CORP | Caneris Thomas A | SVP, GC and Secreta ... | Option Exercise | M | 14.89 | 15,791 | 235,128 | 25,000 | |
May 13 2014 | PMC | PharMerica CORP | Caneris Thomas A | SVP, GC and Secreta ... | Sell | S | 28.60 | 12,192 | 348,691 | 75,702 | 87.9 K to 75.7 K (-13.87 %) |
May 13 2014 | PMC | PharMerica CORP | Caneris Thomas A | SVP, GC and Secreta ... | Payment of Exercise | F | 27.91 | 20,170 | 562,945 | 87,894 | 108.1 K to 87.9 K (-18.66 %) |
May 13 2014 | PMC | PharMerica CORP | Caneris Thomas A | SVP, GC and Secreta ... | Buy | M | 10.84 | 28,764 | 311,802 | 108,064 | 79.3 K to 108.1 K (+36.27 %) |
May 13 2014 | PMC | PharMerica CORP | Caneris Thomas A | SVP, GC and Secreta ... | Payment of Exercise | F | 27.91 | 12,193 | 340,307 | 79,300 | 91.5 K to 79.3 K (-13.33 %) |
May 13 2014 | PMC | PharMerica CORP | Caneris Thomas A | SVP, GC and Secreta ... | Buy | M | 14.89 | 15,791 | 235,128 | 91,493 | 75.7 K to 91.5 K (+20.86 %) |
Mar 27 2014 | PMC | PharMerica CORP | Caneris Thomas A | SVP, GC and Secreta ... | Payment of Exercise | F | 27.02 | 2,166 | 58,525 | 75,702 | 77.9 K to 75.7 K (-2.78 %) |
Mar 13 2014 | PMC | PharMerica CORP | Caneris Thomas A | SVP, GC and Secreta ... | Payment of Exercise | F | 24.76 | 7,271 | 180,030 | 77,868 | 85.1 K to 77.9 K (-8.54 %) |
Mar 13 2014 | PMC | PharMerica CORP | Caneris Thomas A | SVP, GC and Secreta ... | Grant | A | 0.00 | 19,052 | 0 | 85,139 | 66.1 K to 85.1 K (+28.83 %) |
Mar 13 2014 | PMC | PharMerica CORP | Caneris Thomas A | SVP, GC and Secreta ... | Grant | A | 0.00 | 8,961 | 0 | 66,087 | 57.1 K to 66.1 K (+15.69 %) |
Mar 07 2014 | PMC | PharMerica CORP | Caneris Thomas A | SVP, GC and Secreta ... | Option Exercise | M | 15.10 | 21,400 | 323,140 | 0 | |
Mar 07 2014 | PMC | PharMerica CORP | Caneris Thomas A | SVP, GC and Secreta ... | Sell | S | 25.60 | 5,562 | 142,408 | 57,126 | 62.7 K to 57.1 K (-8.87 %) |
Mar 07 2014 | PMC | PharMerica CORP | Caneris Thomas A | SVP, GC and Secreta ... | Sell | S | 25.59 | 8,795 | 225,071 | 62,688 | 71.5 K to 62.7 K (-12.30 %) |
Mar 07 2014 | PMC | PharMerica CORP | Caneris Thomas A | SVP, GC and Secreta ... | Payment of Exercise | F | 25.58 | 15,838 | 405,136 | 71,483 | 87.3 K to 71.5 K (-18.14 %) |
Mar 07 2014 | PMC | PharMerica CORP | Caneris Thomas A | SVP, GC and Secreta ... | Buy | M | 15.10 | 21,400 | 323,140 | 87,321 | 65.9 K to 87.3 K (+32.46 %) |
Mar 06 2014 | PMC | PharMerica CORP | Caneris Thomas A | SVP, GC and Secreta ... | Payment of Exercise | F | 25.20 | 1,831 | 46,141 | 65,921 | 67.8 K to 65.9 K (-2.70 %) |
Mar 05 2014 | PMC | PharMerica CORP | Caneris Thomas A | SVP, GC and Secreta ... | Payment of Exercise | F | 25.01 | 1,004 | 25,110 | 67,752 | 68.8 K to 67.8 K (-1.46 %) |
Jan 23 2014 | PMC | PharMerica CORP | Caneris Thomas A | SVP, GC and Secreta ... | Payment of Exercise | F | 25.26 | 2,503 | 63,226 | 68,756 | 71.3 K to 68.8 K (-3.51 %) |
Nov 15 2013 | PMC | PharMerica CORP | Caneris Thomas A | SVP, GC and Secreta ... | Option Exercise | M | 16.75 | 67,481 | 1,130,307 | 0 | |
Nov 15 2013 | PMC | PharMerica CORP | Caneris Thomas A | SVP, GC and Secreta ... | Payment of Exercise | F | 20.25 | 60,081 | 1,216,640 | 71,259 | 131.3 K to 71.3 K (-45.74 %) |
Nov 15 2013 | PMC | PharMerica CORP | Caneris Thomas A | SVP, GC and Secreta ... | Buy | M | 16.75 | 67,481 | 1,130,307 | 131,340 | 63.9 K to 131.3 K (+105.67 %) |
Mar 27 2013 | PMC | PharMerica CORP | Caneris Thomas A | SVP, GC and Secreta ... | Payment of Exercise | F | 14.03 | 1,548 | 21,718 | 63,859 | 65.4 K to 63.9 K (-2.37 %) |
Mar 06 2013 | PMC | PharMerica CORP | Caneris Thomas A | SVP, GC and Secreta ... | Payment of Exercise | F | 14.48 | 2,058 | 29,800 | 65,407 | 67.5 K to 65.4 K (-3.05 %) |
Mar 06 2013 | PMC | PharMerica CORP | Caneris Thomas A | SVP, GC and Secreta ... | Grant | A | 0.00 | 5,630 | 0 | 67,465 | 61.8 K to 67.5 K (+9.10 %) |
Mar 06 2013 | PMC | PharMerica CORP | Caneris Thomas A | SVP, GC and Secreta ... | Grant | A | 0.00 | 15,023 | 0 | 61,835 | 46.8 K to 61.8 K (+32.09 %) |
Mar 05 2013 | PMC | PharMerica CORP | Caneris Thomas A | SVP, GC and Secreta ... | Payment of Exercise | F | 14.56 | 1,972 | 28,712 | 46,812 | 48.8 K to 46.8 K (-4.04 %) |
Jan 23 2013 | PMC | PharMerica CORP | Caneris Thomas A | SVP, GC and Secreta ... | Payment of Exercise | F | 15.00 | 2,671 | 40,065 | 48,784 | 51.5 K to 48.8 K (-5.19 %) |
Mar 28 2012 | PMC | PharMerica CORP | Caneris Thomas A | SVP, GC and Secreta ... | Payment of Exercise | F | 12.44 | 1,510 | 18,784 | 51,455 | 53 K to 51.5 K (-2.85 %) |
Jan 20 2012 | PMC | PharMerica CORP | Caneris Thomas A | SVP, GC and Secreta ... | Grant | A | 0.00 | 19,138 | 0 | 52,965 | 33.8 K to 53 K (+56.58 %) |
Nov 21 2011 | PMC | PharMerica CORP | Caneris Thomas A | SVP, GC and Secreta ... | Payment of Exercise | F | 15.33 | 2,074 | 31,794 | 33,827 | 35.9 K to 33.8 K (-5.78 %) |
Apr 01 2011 | PMC | PharMerica CORP | Caneris Thomas A | SVP, GC and Secreta ... | Option Exercise | A | 10.84 | 38,352 | 415,736 | 38,352 | |
Apr 01 2011 | PMC | PharMerica CORP | Caneris Thomas A | SVP, GC and Secreta ... | Grant | A | 0.00 | 12,701 | 0 | 35,901 | 23.2 K to 35.9 K (+54.75 %) |
Apr 01 2011 | PMC | PharMerica CORP | Caneris Thomas A | SVP, GC and Secreta ... | Grant | A | 0.00 | 8,237 | 0 | 23,200 | 15 K to 23.2 K (+55.05 %) |
Dec 06 2010 | PMC | PharMerica CORP | Caneris Thomas A | SVP, GC and Secreta ... | Sell | S | 11.20 | 600 | 6,720 | 14,963 | 15.6 K to 15 K (-3.86 %) |
Dec 06 2010 | PMC | PharMerica CORP | Caneris Thomas A | SVP, GC and Secreta ... | Sell | S | 11.20 | 900 | 10,081 | 15,563 | 16.5 K to 15.6 K (-5.47 %) |
Nov 19 2010 | PMC | PharMerica CORP | Caneris Thomas A | SVP, GC and Secreta ... | Payment of Exercise | F | 11.07 | 2,074 | 22,959 | 16,463 | 18.5 K to 16.5 K (-11.19 %) |
Aug 25 2010 | PMC | PharMerica CORP | Caneris Thomas A | SVP, GC and Secreta ... | Payment of Exercise | F | 7.27 | 3,826 | 27,815 | 18,537 | 22.4 K to 18.5 K (-17.11 %) |
Mar 18 2010 | PMC | PharMerica CORP | Caneris Thomas A | SVP, GC and Secreta ... | Option Exercise | A | 18.48 | 33,565 | 620,281 | 33,565 | |
Nov 19 2009 | PMC | PharMerica CORP | Caneris Thomas A | SVP, GC and Secreta ... | Grant | A | 0.00 | 11,633 | 0 | 22,363 | 10.7 K to 22.4 K (+108.42 %) |
Mar 05 2009 | PMC | PharMerica CORP | Caneris Thomas A | SVP, GC and Secreta ... | Option Exercise | A | 14.89 | 40,791 | 607,378 | 40,791 | |
Mar 12 2008 | PMC | PharMerica CORP | Caneris Thomas A | SVP, GC and Secreta ... | Option Exercise | A | 15.10 | 21,227 | 320,528 | 21,227 | |
Aug 23 2007 | PMC | PharMerica CORP | Caneris Thomas A | SVP, GC and Secreta ... | Option Exercise | A | 16.75 | 67,481 | 1,130,307 | 67,481 | |
Aug 23 2007 | PMC | PharMerica CORP | Caneris Thomas A | SVP, GC and Secreta ... | Grant | A | 0.00 | 10,730 | 0 | 10,730 | 0 to 10.7 K |
Page: 1